Chemours (CC) said Wednesday that it now expects fiscal Q2 net sales to reach the high end of its previously announced forecast of a low to mid-teens sequential increase.

Analysts polled by FactSet expect a fiscal Q2 net sales of $1.56 billion.

The company also said it now expects fiscal Q2 adjusted EBITDA of $215 million to $225 million as adjusted EBITDA from its Titanium Technologies segment is estimated to decline by about 15% sequentially due to operational disruptions at certain US sites.

Chemours previously estimated a 40% to 45% increase in fiscal Q2 adjusted EBITDA.